European healthcare stocks tumble as Trump prepares new tariffs, with pharmaceutical firms bracing for economic fallout and market uncertainty.

Nomura believes that pharma tariffs may not be imposed today, but postponed to a later date. It said the US may reiterate its ...

European stocks were set to drop after US President Donald Trump unveiled his plans for new tariffs on US trading partners ...

Investors in pharma and auto stocks are anxious ahead of the April 2 deadline for US tariffs. Despite a 6% fall over three ...

The impending announcement of US tariffs, dubbed "Liberation Day" by Trump, is generating anxiety among investors. Ahead of the announcement, European stock markets have seen notable declines, ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

European shares declined on Wednesday, dragged down in particular by healthcare stocks, as investors awaited tariff plans ...

Shares of Phathom Pharmaceuticals fell after the company said Chief Executive Officer Terrie Curran has resigned and will be succeeded by SaNOtize's Steven Basta. The stock declined 22% to $4.88 on ...

with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, there's been a 0.1% fall in the Zacks Consensus EPS estimate. At present, Vertex Pharmaceuticals boasts ...

Indian equity benchmarks advanced on Thursday, driven by gains in heavyweight financials, although a decline in Tata Motors ...

Sales in the Crop Science segment decreased 2.3%. Pharmaceuticals segment sales increased 2.4%, while Consumer Health sales declined 0.9% on a currency and portfolio-adjusted basis. In the ...